| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/S41366-019-0383-3 |
| P698 | PubMed publication ID | 31164725 |
| P50 | author | Noman Bin Abid | Q92525929 |
| P2093 | author name string | Myeong Ok Kim | |
| Min Woo Kim | |||
| Min Gi Jo | |||
| Myeung Hoon Jo | |||
| P2860 | cites work | Inflammation and metabolic disorders | Q27860923 |
| Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor. | Q27936252 | ||
| Obesity | Q28275029 | ||
| The adipocyte-secreted protein Acrp30 enhances hepatic insulin action | Q28505765 | ||
| The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity | Q28506782 | ||
| Mitotic clonal expansion: a synchronous process required for adipogenesis | Q28588756 | ||
| Disruption of adiponectin causes insulin resistance and neointimal formation | Q28589597 | ||
| Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001 | Q29614193 | ||
| Adipocyte differentiation from the inside out | Q29615690 | ||
| Obesity as a medical problem | Q29616305 | ||
| Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 | Q29616834 | ||
| A central role for JNK in obesity and insulin resistance | Q29619778 | ||
| Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease | Q33580624 | ||
| Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction | Q33839167 | ||
| New insight into adiponectin role in obesity and obesity-related diseases | Q33943727 | ||
| Exendin-4 Improves Nonalcoholic Fatty Liver Disease by Regulating Glucose Transporter 4 Expression in ob/ob Mice | Q34097903 | ||
| Adiponectin-induced ERK and Akt phosphorylation protects against pancreatic beta cell apoptosis and increases insulin gene expression and secretion | Q34231901 | ||
| Mechanisms underlying current and future anti-obesity drugs | Q34322175 | ||
| Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance | Q34718730 | ||
| The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice | Q35108391 | ||
| Activation and centromeric localization of CCAAT/enhancer-binding proteins during the mitotic clonal expansion of adipocyte differentiation | Q35205402 | ||
| Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase | Q35857117 | ||
| AMPK, the metabolic syndrome and cancer | Q36024356 | ||
| Ageing and metabolism: drug discovery opportunities | Q36174012 | ||
| Keynote review: the adipocyte as a drug discovery target | Q36280813 | ||
| Functions of AMP-activated protein kinase in adipose tissue. | Q36482345 | ||
| A short-term transition from a high-fat diet to a normal-fat diet before pregnancy exacerbates female mouse offspring obesity | Q36767698 | ||
| Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases | Q37366361 | ||
| AMPK: an emerging drug target for diabetes and the metabolic syndrome | Q37471010 | ||
| Establishment of preadipocyte clonal line from epididymal fat pad of ob/ob mouse that responds to insulin and to lipolytic hormones | Q37596569 | ||
| GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. | Q37625838 | ||
| Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits | Q37660915 | ||
| Anti-obesity drugs: past, present and future | Q38036925 | ||
| Adipocyte and adipogenesis. | Q38123314 | ||
| Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists | Q38318111 | ||
| Analysis of cell cycle arrest in adipocyte differentiation | Q38328872 | ||
| Osmotin: a plant sentinel and a possible agonist of mammalian adiponectin | Q38411025 | ||
| Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high-fat diet feeding in mice. | Q38970746 | ||
| 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase | Q40370485 | ||
| The effects of AICAR on adipocyte differentiation of 3T3-L1 cells | Q40783109 | ||
| Globular adiponectin resistance develops independently of impaired insulin-stimulated glucose transport in soleus muscle from high-fat-fed rats | Q42170113 | ||
| Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression. | Q42437602 | ||
| Trans-10, cis-12 conjugated linoleic acid increases fatty acid oxidation in 3T3-L1 preadipocytes | Q42518291 | ||
| Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. | Q42803586 | ||
| Understanding adipocyte differentiation | Q46119331 | ||
| Vanillic acid attenuates obesity via activation of the AMPK pathway and thermogenic factors in vivo and in vitro | Q47398764 | ||
| Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake | Q48111745 | ||
| The Adiponectin Homolog Osmotin Enhances Neurite Outgrowth and Synaptic Complexity via AdipoR1/NgR1 Signaling in Alzheimer's Disease. | Q50041710 | ||
| Adiponectin: A potential therapeutic target for metabolic syndrome | Q50208228 | ||
| Gintonin Mitigates MPTP-Induced Loss of Nigrostriatal Dopaminergic Neurons and Accumulation of α-Synuclein via the Nrf2/HO-1 Pathway. | Q52718062 | ||
| Adiponectin Enhances Cold-Induced Browning of Subcutaneous Adipose Tissue via Promoting M2 Macrophage Proliferation. | Q55053401 | ||
| Correction: Structural and Functional Similarities between Osmotin from Nicotiana Tabacum Seeds and Human Adiponectin. | Q55521186 | ||
| A common bicyclic protein kinase cascade inactivates the regulatory enzymes of fatty acid and cholesterol biosynthesis | Q69907652 | ||
| Obesity: Metabolically healthy obesity and NAFLD | Q87775200 | ||
| Metabolic adaptation and maladaptation in adipose tissue | Q92426430 | ||
| Adiponectin homolog novel osmotin protects obesity/diabetes-induced NAFLD by upregulating AdipoRs/PPARα signaling in ob/ob and db/db transgenic mouse models | Q93349706 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 2422-2433 | |
| P577 | publication date | 2019-06-04 | |
| P1433 | published in | International Journal of Obesity | Q6051519 |
| P1476 | title | Adiponectin homolog osmotin, a potential anti-obesity compound, suppresses abdominal fat accumulation in C57BL/6 mice on high-fat diet and in 3T3-L1 adipocytes | |
| P478 | volume | 43 |
| Q92537528 | Examining the Potential of Developing and Implementing Use of Adiponectin-Targeted Therapeutics for Metabolic and Cardiovascular Diseases | cites work | P2860 |
Search more.